重组SARS-COV-2刺突RBD(hFc标签) 冠状病毒蛋白靶点

重组SARS-COV-2刺突RBD(hFc标签) 冠状病毒蛋白靶点

产品说明书

FAQ

COA

已发表文献

 

SARS-CoV-2, which causes the global pandemic coronavirus disease 2019 (Covid-19), belongs to a family of viruses known as coronaviruses that also include MERS‑CoV and SARS-CoV-1. Coronaviruses are commonly comprised of four structural proteins: Spike protein (S), Envelope protein (E), Membrane protein (M) and Nucleocapsid protein (N). The SARS-CoV-2 S protein is a glycoprotein that mediates membrane fusion and viral entry. The S protein is homotrimeric, with each ~180-kDa monomer consisting of two subunits, S1 and S2 .The RBD of SARS-CoV-2 binds a metallopeptidase, angiotensin-converting enzyme 2 (ACE-2). Before binding to the ACE-2 receptor, structural analysis of the S1 trimer shows that only one of the three RBD domains is in the "up" conformation. This is an unstable and transient state that passes between trimeric subunits but is nevertheless an exposed state to be targeted for neutralizing antibody therapy. Polyclonal antibodies to the RBD of the SARS-CoV-2 protein have been shown to inhibit interaction with the ACE-2 receptor, confirming RBD as an attractive target for vaccinations or antiviral therapy. There is also promising work showing that the RBD may be used to detect presence of neutralizing antibodies present in a patient's bloodstream, consistent with developed immunity after exposure to the SARS-CoV-2.

 

产品性质

别名

S protein RBD; S glycoprotein RBD; Spike protein RBD

Accession

QHD43416.1

表达区间及表达系统

Recombinant SARS-COV-2 Spike RBD Protein is expressed from HEK293 Cells with hFc tag at the C-terminal. It contains Arg319-Phe541.

分子量

Approximately 50.7 kDa. Due to glycosylation, the protein migrates to 55-70 kDa based on Tris-Bis PAGE result.

纯度

> 95% as determined by SDS-PAGE and HPLC.

内毒素

1.0 EU per 1μg of the protein by the LAL method.

制剂

Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). Normally 5% trehalose is added as protectant before lyophilization.

复溶

Centrifuge tubes before opening. Reconstituting to a concentration more than 100 μg/mL is recommended (usually we use 1 mg/mL solution for lyophilization). Dissolve the lyophilized protein in distilled water.

 

运输与保存方法

冰袋运输-20存,一年有效期

复溶后,20 °C,在未开封状态下保存 3-6 个月复溶后,2-8°C 保存 2-7 天。

建议第一次使用时分装存,避免反复冻融

 

注意事项

  1. 避免反复冻融。
  2. 为了您的安全和健康,请穿实验服并戴一次性手套操作。
  3. 本产品仅作科研用途!
  4.  

产品数据

重组SARS-COV-2刺突RBD(hFc标签) 冠状病毒蛋白靶点

 

HB221025

 

重组SARS-COV-2刺突RBD(hFc标签) 冠状病毒蛋白靶点

暂无内容

重组SARS-COV-2刺突RBD(hFc标签) 冠状病毒蛋白靶点

暂无内容

 

SARS-CoV-2, which causes the global pandemic coronavirus disease 2019 (Covid-19), belongs to a family of viruses known as coronaviruses that also include MERS‑CoV and SARS-CoV-1. Coronaviruses are commonly comprised of four structural proteins: Spike protein (S), Envelope protein (E), Membrane protein (M) and Nucleocapsid protein (N). The SARS-CoV-2 S protein is a glycoprotein that mediates membrane fusion and viral entry. The S protein is homotrimeric, with each ~180-kDa monomer consisting of two subunits, S1 and S2 .The RBD of SARS-CoV-2 binds a metallopeptidase, angiotensin-converting enzyme 2 (ACE-2). Before binding to the ACE-2 receptor, structural analysis of the S1 trimer shows that only one of the three RBD domains is in the "up" conformation. This is an unstable and transient state that passes between trimeric subunits but is nevertheless an exposed state to be targeted for neutralizing antibody therapy. Polyclonal antibodies to the RBD of the SARS-CoV-2 protein have been shown to inhibit interaction with the ACE-2 receptor, confirming RBD as an attractive target for vaccinations or antiviral therapy. There is also promising work showing that the RBD may be used to detect presence of neutralizing antibodies present in a patient's bloodstream, consistent with developed immunity after exposure to the SARS-CoV-2.

 

产品性质

别名

S protein RBD; S glycoprotein RBD; Spike protein RBD

Accession

QHD43416.1

表达区间及表达系统

Recombinant SARS-COV-2 Spike RBD Protein is expressed from HEK293 Cells with hFc tag at the C-terminal. It contains Arg319-Phe541.

分子量

Approximately 50.7 kDa. Due to glycosylation, the protein migrates to 55-70 kDa based on Tris-Bis PAGE result.

纯度

> 95% as determined by SDS-PAGE and HPLC.

内毒素

1.0 EU per 1μg of the protein by the LAL method.

制剂

Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). Normally 5% trehalose is added as protectant before lyophilization.

复溶

Centrifuge tubes before opening. Reconstituting to a concentration more than 100 μg/mL is recommended (usually we use 1 mg/mL solution for lyophilization). Dissolve the lyophilized protein in distilled water.

 

运输与保存方法

冰袋运输-20存,一年有效期

复溶后,20 °C,在未开封状态下保存 3-6 个月复溶后,2-8°C 保存 2-7 天。

建议第一次使用时分装存,避免反复冻融

 

注意事项

  1. 避免反复冻融。
  2. 为了您的安全和健康,请穿实验服并戴一次性手套操作。
  3. 本产品仅作科研用途!
  4.  

产品数据

重组SARS-COV-2刺突RBD(hFc标签) 冠状病毒蛋白靶点

 

HB221025

 

重组SARS-COV-2刺突RBD(hFc标签) 冠状病毒蛋白靶点

暂无内容

重组SARS-COV-2刺突RBD(hFc标签) 冠状病毒蛋白靶点

暂无内容